Skip to main content
OpenTrials
Completed

NCT Number: NCT03362112

Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes

Lipoprotein-associated phospholipase A2 (LP-PLA2) is a good marker of cardiovascular risk and inflammation. This study aims at the characteristic and clinical significance of LP-PLA2 test in patients with type 2 diabetes(T2D).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type2 Diabetes

Sex eligibility

All sexes

Study type

Observational

About this study

The investigators recorded clinical factors, serum levels of glucose, HbA1c, lipids and LP-PLA2 in patients with T2D who visited in the Department of Endocrinology at the Nanjing First Hospital from January 2015 to August 2016. The relationship between levels of LP-PLA2 and diabetic complications are analysed.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with T2D and the diagnostic criteria of T2D is according to the World Health Organization in 1999.

Exclusion criteria

  • Patients use systemic steroidal anti-inflammatory drugs.
  • Patients are pregnant.
  • Patients with an acute infection.

Treatment and study plan

Primary outcomes

  1. Lipoprotein-associated Phospholipase A2

    Time frame: Day one

    the plasma lipoprotein-associated phospholipase A2 level of patients

Secondary outcomes

  1. HbA1c

    Time frame: Day one

    the glycosylated hemoglobin level of patients

  2. LDL-c

    Time frame: Day one

    low density lipoprotein cholesterol

  3. Diabetic Complication

    Time frame: Day one

    the prevalence of atherosclerosis, diabetic Nephropathy, diabetic retinopathy and diabetic neuropathy

  4. C Peptide

    Time frame: Day one

    fast and 120min postprandial C peptide

Sponsors and collaborators

Lead sponsor

Nanjing First Hospital, Nanjing Medical University

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2017
First posted
Dec 5, 2017
Registry last updated
Apr 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.